SILENCING OF ANGPTL4 VIA ANTISENSE OLIGONUCLEOTIDES EFFECTIVELY REDUCES PLASMA TRIGLYCERIDE AND GLUCOSE LEVELS IN MICE WITHOUT CAUSING LYMPHADENOPATHY

被引：0
|
作者：
Nilsson, S. K. [1 ]
Deng, M. [2 ]
Kutrolli, E. [1 ]
Motamedi, M. [1 ]
Olivecrona, G. [3 ]
Kersten, S. [2 ]
机构：
[1] Lipigon Pharmaceut AB, Head Off, Umea, Sweden
[2] Wageningen Univ, Div Human Nutr & Hlth, Nutr Metab & Genom Grp, Wageningen, Netherlands
[3] Umea Univ, Med Biosci, Umea, Sweden
来源：
ATHEROSCLEROSIS | 2022年 / 355卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O065
引用
收藏
页码：E25 / E25
页数：1
相关论文
共 17 条
  • [1] ANGPTL4 silencing via antisense oligonucleotides reduces plasma triglycerides and glucose in mice without causing lymphadenopathy
    Deng, Mingjuan
    Kutrolli, Elda
    Sadewasser, Anne
    Michel, Sven
    Joibari, Masoumeh Motamedi
    Jaschinski, Frank
    Olivecrona, Gunilla
    Nilsson, Stefan K.
    Kersten, Sander
    JOURNAL OF LIPID RESEARCH, 2022, 63 (07)
  • [2] Regulation of plasma triglyceride partitioning by adipose-derived ANGPTL4 in mice
    Spitler, Kathryn M.
    Shetty, Shwetha K.
    Cushing, Emily M.
    Sylvers-Davie, Kelli L.
    Davies, Brandon S. J.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [3] Regulation of plasma triglyceride partitioning by adipose-derived ANGPTL4 in mice
    Kathryn M. Spitler
    Shwetha K. Shetty
    Emily M. Cushing
    Kelli L. Sylvers-Davie
    Brandon S. J. Davies
    Scientific Reports, 11
  • [4] ANGPTL4 E40K AND T266M: EFFECTS ON PLASMA TRIGLYCERIDE AND HDL LEVELS, ANGPTL4 LEVELS AND CHD RISK
    Smart, M. C.
    Ehnholm, C.
    Jauhiainen, M.
    Robciuc, M.
    Cooper, J. A.
    Drenos, F.
    Humphries, S. E.
    Talmud, P. J.
    ATHEROSCLEROSIS, 2009, 207 (01) : E6 - E6
  • [5] ANGPTL4 VARIANTS ARE ASSOCIATED WITH LOWER PLASMA TRIGLYCERIDE LEVELS AND IMPROVED POSTPRANDIAL RESPONSES
    Talmud, P. J.
    Smart, M.
    Presswood, E.
    Cooper, J. A.
    Drenos, F.
    Nicaud, V.
    Humphries, S. E.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 7 - 7
  • [6] Administration of Apolipoprotein CIII Antisense Oligonucleotides to ob/ob Mice Reduces Hepatic ApocIII mRNA Expression and Plasma Triglyceride and Improves Glucose Tolerance
    Lee, Richard
    Fu, Wuxia
    Bell, Thomas A.
    Mullick, Adam E.
    Graham, Mark
    Crooke, Rosanne
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (11) : E290 - E290
  • [7] ANGPTL4 Variants are Associated with Lower Plasma Triglyceride Levels and Improved Postprandial Responses, but Increased CHD Risk, Independent of Triglycerides
    Smart, M.
    Presswood, E.
    Cooper, J. A.
    Drenos, F.
    Palmen, J.
    Humphries, S. E.
    Talmud, P. J.
    JOURNAL OF NUTRIGENETICS AND NUTRIGENOMICS, 2008, 1 (1-2) : 85 - 86
  • [8] Caloric Restriction and Exercise Increase Plasma ANGPTL4 Levels in Humans via Elevated Free Fatty Acids
    Kersten, Sander
    Lichtenstein, Laeticia
    Steenbergen, Emma
    Mudde, Karin
    Hendriks, Henk F. J.
    Hesselink, Matthijs K.
    Schrauwen, Patrick
    Muller, Michael
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (06) : 969 - U466
  • [9] Liver-targeted Angptl4 silencing by antisense oligonucleotide treatment attenuates hyperlipidaemia and atherosclerosis development in APOE*3-Leiden.CETP mice
    Modder, Melanie
    Panhuis, Wietse In Het
    Li, Mohan
    Afkir, Salwa
    Dorn, Alexandra L.
    Pronk, Amanda C. M.
    Streefland, Trea C. M.
    Lalai, Reshma A.
    Pierrou, Stefan
    Nilsson, Stefan K.
    Olivecrona, Gunilla
    Kooijman, Sander
    Rensen, Patrick C. N.
    Schonke, Milena
    CARDIOVASCULAR RESEARCH, 2024, 120 (17) : 2179 - 2190
  • [10] Angptl4 deficiency decreases serum triglyceride levels in low-density lipoprotein receptor knockout mice and streptozotocin-induced diabetic mice
    Adachi, Hironori
    Kondo, Tatsuya
    Koh, Gou Young
    Nagy, Andras
    Oike, Yuichi
    Araki, Eiichi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 409 (02) : 177 - 180
12